Clover Health releases transcript of 2Q26 supplemental Q&A on earnings call
Reuters2026/08/20 20:34- Clover Health posted a 2Q26 supplemental shareholder Q&A transcript featuring remarks from CEO Andrew Toy.
- Cohort maturation under Clover Assistant cited as key driver, with year-3 members generating about $155 PMPM more insurance gross profit than year-1.
- Year-3 Clover Assistant-managed cohort showed an MCR about 18% better than non-assisted members, framed as compounding economics over time.
- CMS rated Clover’s PPO and HMO plans at 4.5 Stars for the 2027 payment year; management said it is operating on that basis.
- Counterpart Health positioned to prioritize lives under management and demonstrated impact before material financial contribution, with “real-time value-based payment” models under consideration.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Broadcom seeks over $60 billions in debt financing to provide chip infrastructure for AI companies such as Anthropic
Broadcom is in discussions with Blackstone and Apollo, planning to raise over $60 billion in debt financing through a special purpose vehicle (SPV). The total size may reach $100 billion, which will be used to support AI chip infrastructure construction, with Anthropic as a representative project. This deal continues the “AI XPV Partnership” framework established by the three parties in June this year.
Jones Ventures Intl Acquisition1 net loss widens to $43,605 in Q2 FY26
CleanCore Solutions says 502,090,260 shares outstanding after follow-on offering issuance
Crypto prices
More
